Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,063 | -20,578 | -14,732 | -23,404 | -21,884 |
| Depreciation Amortization | 1,263 | 2,943 | 2,081 | 1,025 | 558 |
| Accounts payable and accrued liabilities | -508 | 264 | 677 | 219 | 190 |
| Other Working Capital | 823 | 1,771 | 850 | 620 | 21,941 |
| Other Operating Activity | 1,730 | 842 | 53 | 12,808 | -2,397 |
| Operating Cash Flow | $-18,755 | $-14,758 | $-11,071 | $-8,732 | $-1,591 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -265,729 | -1,730 | 3,030 | -13,470 | N/A |
| Investing Cash Flow | $-265,729 | $-1,730 | $3,030 | $-13,470 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 2,500 |
| Common Stock Issued | 305,000 | 22,999 | 11,571 | 25,415 | N/A |
| Other Financing Activity | -4,725 | -599 | -1,222 | -3,201 | -332 |
| Financing Cash Flow | $300,275 | $22,400 | $10,349 | $22,214 | $2,168 |
| Beginning Cash Position | 8,988 | 3,076 | 769 | 756 | 180 |
| End Cash Position | 24,779 | 8,988 | 3,076 | 769 | 756 |
| Net Cash Flow | $15,791 | $5,912 | $2,307 | $13 | $576 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,755 | -14,758 | -11,071 | -8,732 | -1,591 |
| Free Cash Flow | -18,755 | -14,758 | -11,071 | -8,732 | -1,591 |